Analysis of the pH Dependence of the Neonatal Fc Receptor/Immunoglobulin G Interaction Using Antibody and Receptor Variants
The DOI matches its Crossref record.
Abstract
The neonatal Fc receptor (FcRn) binds maternal immunoglobulin G (IgG) from ingested milk in the gut (pH 6.0-6.5) and delivers it to the bloodstream of the newborn (pH 7.0-7.5). A soluble version of FcRn reproduces the physiological pH-dependent interaction with IgG, showing high-affinity binding at pH 6.0-6.5 but weak or no binding at pH 7.0-7.5. We have studied the pH dependence of the FcRn/IgG interaction using a surface plasmon resonance assay to measure kinetic and equilibrium constants. We show that the affinity of FcRn for IgG is reduced about 2 orders of magnitude as the pH is raised from 6.0 to 7.0. A hill put analysis suggests that several titrating residues participate in the pH-dependent affinity transition. Histidine side chains are likely candidate for residues that titrate between pH 6.0 and 7.0, and previous biochemical and structural work identified several histidines on the Fc portion of IgG that are located at the FcRn binding site. Using mutant IgG molecules and IgG subtype variants that differ in the number of histidines at the IgG/FcRn interface, we demonstrate that IgG histidines located at the junction between the CH2 and CH3 domains (residues 310 and 433) contribute to the pH-dependent affinity transition. Experiments with a mutant FcRn molecule show that two histidines on the FcRn heavy chain (residues 250 and 251) also contribute to the pH dependence of the FcRn/IgG interaction. There results are interpreted using the crystal structures of FcRn and an FcRn/Fc complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This characteristic is likely mediated, at least in part, via protonation of histidine residues (the only amino acid that changes between pH 5.5 and 7.4) at the CH2–CH3 domain interface of IgG (54–56).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [54]
In the citing paper
“the interaction of FcRn with IgG displays a strong pH dependence, such that high-affinity binding occurs at pH 6.0, but little or no binding occurs at physiological pH 7.4 (54).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [54]
Citations
Cites
Still being checked.
Cited by
Items 201–300 of 317
Fujimoto, K., Ida, H., Hirota, Y., Ishigai, M., Amano, J., & Tanaka, Y. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099184 · Cited by 18
Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery
Zhou, L. J., Wang, H.-Y., Tong, S., Okamoto, C. T., Shen, W., & Zaro, J. L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.051 · Cited by 16
Kenniston, J. A., Taylor, B. M., Conley, G. P., Cosic, J., Kopacz, K. J., Lindberg, A. P., Comeau, S. R., Atkins, K., Bullen, J., TenHoor, C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807396 · Cited by 15
Murai, A., Murota, R., Doi, K., Yoshida, T., Aoyama, H., Kobayashi, M., & Horio, F. (2012) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.12.003 · Cited by 15
Cui, D., Zhang, L., Li, J., Zhao, Y., Hu, X., Dai, Y., Zhang, R., & Li, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115972 · Cited by 16
Lao, B. J., & Kamei, D. T. (2007) · Biotechnology Progress · doi:10.1021/bp070080b · Cited by 15
Membrane-anchored Human FcRn can Oligomerize in the Absence of IgG
Praetor, A., Jones, R. M., Wong, W. L., & Hunziker, W. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00626-5 · Cited by 15
V Region of IgG Controls the Molecular Properties of the Binding Site for Neonatal Fc Receptor
Rossini, S., Noé, R., Daventure, V., Lecerf, M., Justesen, S., & Dimitrov, J. D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000732 · Cited by 14
van Kampen, M. D., de Wilt, L. H. A. M., van Egmond, M. L., Reinders-Blankert, P., van den Bremer, E. T. J., Wang, G., Heck, A. J. R., Parren, P. W. H. I., Beurskens, F. J. M., Schuurman, J., et al. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.02.016 · Cited by 15
Liu, P., Gao, X., Lundin, V., Shi, C., Adem, Y. T., Lin, K., Jiang, G., Kao, Y., Yang, F., Michels, D. A., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04855 · Cited by 14
Tulika, T., Pedersen, R. W., Rimbault, C., Ahmadi, S., Rivera‐de‐Torre, E., Fernández‐Quintero, M. L., Loeffler, J. R., Bohn, M., Ljungars, A., Ledsgaard, L., et al. (2023) · Protein Science · doi:10.1002/pro.4821 · Cited by 11
Ng, C. M. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1997 · Cited by 13
Hameedat, F., Pizarroso, N. A., Teixeira, N., Pinto, S. F. T., & Sarmento, B. F. C. C. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106259 · Cited by 14
Jasinskas, A., & Barbour, A. G. (2005) · Journal of Medical Entomology · doi:10.1093/jmedent/42.3.359 · Cited by 13
Jørstad, Ø. K., Foss, S., Gjølberg, T. T., Mester, S., Nyquist-Andersen, M., Sivertsen, M. S., Fossum, D., Gleditsch, E., Moe, M. C., & Andersen, J. T. (2023) · International Journal of Retina and Vitreous · doi:10.1186/s40942-023-00507-3 · Cited by 12
Sand, K. M. K., Gruber, M., Sandlie, I., Mathiesen, L., Andersen, J. T., & Wadsack, C. (2022) · Placenta · doi:10.1016/j.placenta.2022.07.019 · Cited by 17
Molecular basis for the interaction of Fc receptors with immunoglobulins
Gavin, A. L., Hulett, M. D., & Hogarth, P. M. (1998) · Springer eBooks · doi:10.1007/978-94-011-5018-7_2 · Cited by 12
Introduction: Antibody Structure and Function
Rajpal, A., Strop, P., Yeung, Y. A., Chaparro‐Riggers, J. F., & Pons, J. (2013) · Wiley eBooks · doi:10.1002/9783527675272.ch01 · Cited by 12
Monteiro, J., Fernandes, A., Tato, D. G., Moreira, E., Ribeiro, R. J. T., Reguengo, H., Gonçalves, J., & Fresco, P. (2025) · Cancers · doi:10.3390/cancers17193262 · Cited by 16
Modified Therapeutic Antibodies: Improving Efficacy
Dai, J., Zhang, X., Dai, J., Yang, X.-M., & Chen, Z. (2021) · Engineering · doi:10.1016/j.eng.2020.06.030 · Cited by 14
Reusch, J., Andersen, J. T., Rant, U., & Schlothauer, T. (2024) · mAbs · doi:10.1080/19420862.2024.2361585 · Cited by 17
Complement contributes to antibody-mediated protection against repeated SHIV challenge
Goldberg, B. S., Spencer, D. A., Pandey, S., Ordonez, T., Barnette, P. T., Yun, Y., Gao, L., Dufloo, J., Bruel, T., Schwartz, O., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221247120 · Cited by 13
Access to site-specific Fc–cRGD peptide conjugates through streamlined expressed protein ligation
Frutos, S., Jordan, J. B., Bio, M. M., Muir, T. W., Thiel, O. R., & Vila‐Perelló, M. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01833e · Cited by 11
Ng, C. M., Fielder, P. J., Jin, J., & Deng, R. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9911-4 · Cited by 11
Tulika, T., Ruso‐Julve, F., Ahmadi, S., Ljungars, A., Rivera‐de‐Torre, E., Wade, J., Fernández‐Quintero, M. L., Jenkins, T. P., Belfakir, S. B., Ross, G. M. S., et al. (2024) · Structure · doi:10.1016/j.str.2024.07.014 · Cited by 11
Mannose 6-phosphate receptor-targeting antibodies preserve Fc receptor-mediated recycling
Gauthier, C., Mariot, J., Daurat, M., Dhommée, C., Cheikh, K. E., Morère, E., Depaepe, G., Gary‐Bobo, M., Morère, A., Garcia, M., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.011 · Cited by 12
Abundant Intracellular IgG in Enterocytes and Endoderm Lacking FcRn
Mohanty, S., Kim, J., Ganesan, L. P., Phillips, G. S., Robinson, J. M., & Anderson, C. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070863 · Cited by 10
Bellosta, S., Rossi, C., Alieva, A. S., Catapano, A. L., Corsini, A., & Baragetti, A. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07293-w · Cited by 10
Origin of the apical transcytic membrane system in jejunal absorptive cells of neonates
Kumagai, N., Baba, R., Sakuma, Y., Arita, K., Shinohara, M., Kourogi, M., Fujimoto, S., & Fujita, M. (2011) · Medical Molecular Morphology · doi:10.1007/s00795-010-0506-3 · Cited by 14
Seijsing, J., Lindborg, M., Löfblom, J., Uhlén, M., & Gräslund, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081350 · Cited by 10
Presence of the di-leucine motif in the cytoplasmic tail of the pig FcRn α chain
Zhao, Y., Kacskovıcs, I., Zhao, Z., & Hammarström, L. L. G. (2003) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2003.08.006 · Cited by 10
Niebel, B., Chen, W., Mukai, K., & Henry, C. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104601 · Cited by 10
The Role of Proximal Tubular Cells in the Early Stages of Diabetic Nephropathy
Peres, G. B. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000551 · Cited by 9
Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin
Shiga, Y., Murata, D., Sugimoto, A., Oshima, Y., Tada, M., Ishii‐Watabe, A., Imai, K., Tomii, K., Takeuchi, T., Kagaya, S., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00221 · Cited by 10
Heaps, W. P., Packard, A., McCammon, K. M., Green, T. P., Talley, J. P., Bundy, B. C., & Corte, D. D. (2026) · Biophysica · doi:10.3390/biophysica6010004 · Cited by 10
Bryniarski, M. A., Tuhin, M. T. H., Acker, T. M., Wakefield, D. L., Sethaputra, P., Cook, K. D., Soto, M., Ponce, M., Primack, R., Jagarapu, A., et al. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.06.013 · Cited by 9
Pedreño-López, N., Rosen, B. C., Flores, W. J., Gorman, M. J., Voigt, T. B., Ricciardi, M. J., Crosno, K., Weisgrau, K. L., Parks, C. L., Lifson, J. D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657424 · Cited by 7
The MHC class I-related FcRn ameliorates murine Lyme arthritis
Crowley, H., Alroy, J., Sproule, T. J., Roopenian, D. C., & Huber, B. T. (2006) · International Immunology · doi:10.1093/intimm/dxh380 · Cited by 8
Liu, C., Kim, Y. S., Lowe, J. H.-N., & Chung, S. (2021) · Bioanalysis · doi:10.4155/bio-2021-0099 · Cited by 8
Zhang, C., Kimura, S. R., Weng, Z., Vajda, S., Brower, R. C., & DeLisi, C. (1998) · Journal of the Franklin Institute · doi:10.1016/s0016-0032(97)00020-3 · Cited by 8
Müller, T. R., Tasser, C., Tesar, M., Fucek, I., Schniegler‐Mattox, U., Koch, J., & Ellwanger, K. (2023) · mAbs · doi:10.1080/19420862.2023.2245519 · Cited by 8
Struble, E. B., Ma, L., Zhong, L., Lesher, A. P., Beren, J. J., & Zhang, P. C. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/538701 · Cited by 7
Monoclonal antibodies: Pharmacokinetics as a basis for new dosage regimens?
Perea, J. R. A., Sádaba, B., & Gómez-Guíu, A. (2014) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155214538085 · Cited by 8
Molecular Engineering of Efficacious Mono-Valent Ultra-Long Acting Two-Chain Insulin-Fc Conjugates
Tagmose, T. M., Pedersen, K., Pridal, L., Stidsen, C. E., Pedersen, M. Ø., Lin, Z., Zhang, Y., Wan, Z., Ferreras, M., Naver, H., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02039 · Cited by 8
Wang, M., Ishino, T., Joyce, A. P., Tam, A. S. P., Duan, W., Lin, L., Somers, W. S., Kriz, R., & O’Hara, D. M. (2015) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.11.008 · Cited by 7
Hardiansyah, D., & Ng, C. M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.09.015 · Cited by 7
Menichetti, B. T., García-Guerra, A., Lakritz, J., Weiss, W. P., Velez, J. S., Bothe, H., Merchan, D., & Schuenemann, G. M. (2021) · Journal of Dairy Science · doi:10.3168/jds.2021-20243 · Cited by 8
Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments
Kelly, V. W., & Sirk, S. J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00862 · Cited by 7
Zhang, W., Xiang, Y., Wang, L., Wang, F., Li, G., & Zhuang, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122160 · Cited by 6
Exploiting the neonatal crystallizable fragment receptor to treat kidney disease
Dylewski, J. F., Haddad, G., & Blaine, J. T. (2023) · Kidney International · doi:10.1016/j.kint.2023.09.024 · Cited by 7
The neonatal Fc receptor does not modulate hepatitis C virus neutralization
Morel, A., Passot, C., Arnoult, C., Dumans, A., Beaumont, É., Gouilleux‐Gruart, V., Roingeard, P., & Blanchard, E. (2015) · Journal of General Virology · doi:10.1099/vir.0.000060 · Cited by 6
Interactions Outside the Antigen-Combining Site
Nezlin, R. S. (1998) · Elsevier eBooks · doi:10.1016/b978-012517970-6/50006-0 · Cited by 6
Zakrzewicz, A., Vanderheyden, K., Galaly, Y., Feldhoff, S., Sips, M., Brinkhaus, M., & Tikkanen, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1473637 · Cited by 6
Beffinger, M., Schellhammer, L., Taşkoparan, B., Deplazes, S., Salazar, U., Tatari, N., Seehusen, F., von Balthazar, L., Zinner, C., Spath, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59971-0 · Cited by 9
Barriers for orally inhaled therapeutic antibodies
Sécher, T., & Heuzé‐Vourc'h, N. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2249821 · Cited by 6
Engineering of the Fc Region for Improved PK (FcRn Interaction)
Kenanova, V. E., Olafsen, T., Andersen, J. T., Sandlie, I., & Wu, A. M. (2010) · Springer eBooks · doi:10.1007/978-3-642-01144-3_27 · Cited by 5
Mader, S., Brimberg, L., Soltys, J. N., Bennett, J. L., & Diamond, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01599 · Cited by 6
Human IgG1 Fc pH-dependent optimization from a constant pH molecular dynamics simulation analysis
Lim, Y. Y., Lim, T. S., & Choong, Y. S. (2020) · RSC Advances · doi:10.1039/c9ra10712f · Cited by 5
House, R. V., Broge, T. A., Suscovich, T. J., Snow, D. M., Tomic, M. T., Nonet, G. H., Bajwa, K., Zhu, G., Martinez, Z., Hackett, K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267796 · Cited by 6
Field-Flow Fractionation for Assessing Biomolecular Interactions in Solution
Chou, R., Pollastrini, J., Dillon, T. M., Bondarenko, P. V., Tam, L. T., Miller, J. M., Moxness, M. S., & Cao, S. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0154-4_8 · Cited by 5
Manabe, S., Senga, S., Iwamoto, S., Yarita, H., Takahashi, R., Mitani, A., Sumiyoshi, W., Hoshinoo, A., Hiranyakorn, M., Kinoshita, T., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c10898 · Cited by 6
Jairam, R. K., Franz, M., Hanke, N., & Kuepfer, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1427325 · Cited by 5
Engineering of Non-CDR Loops in Immunoglobulin Domains
Rüker, F., & Wozniak‐Knopp, G. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596773.020 · Cited by 4
Role of β-microseminoprotein from prostate cancer initiation to recurrence: A mini-review
Karunasinghe, N. (2014) · World Journal of Clinical Urology · doi:10.5410/wjcu.v3.i1.20 · Cited by 5
Azevedo, C., Andersen, J. T., Traverso, G., & Sarmento, B. F. C. C. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.009 · Cited by 6
van Montfort, T., Thomas, A. A. M., Krawczyk, P. M., Berkhout, B., Sanders, R. W., & Paxton, W. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402344 · Cited by 4
Biology of Gut Immunoglobulins
Johansen, F., Massol, R., Baker, K., Fiebiger, E., Blumberg, R. S., & Lencer, W. I. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00039-7 · Cited by 4
Simister, N. E. (1998) · Springer eBooks · doi:10.1007/978-94-011-5018-7_6 · Cited by 4
Research progress on neonatal Fc receptor and its application
Hu, M., Wei, S., Zhou, W., & Wang, P. (2021) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2021-0252 · Cited by 4
Safety and tolerability of anti-FcRn monoclonal antibody in thyroid autoimmunity
Wolf, J., Krämer, I., & Kahaly, G. J. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00145 · Cited by 2
Newland, A. C., & McDonald, V. (2020) · Annals of Blood · doi:10.21037/aob-20-55 · Cited by 3
Transfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheep
Argun, T. C., Tök, Ö., Tök, L., Yılmaz, G., Yılmaz, F. M., Gunes, A. S., Argun, M., & Butuner, O. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.07.08 · Cited by 2
An antidote approach to reduce risk and broaden utility of antibody-based therapeutics
Portnoff, A. D., Gao, C., Borrok, M. J., Gao, X., Gao, C., & Rainey, G. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775528 · Cited by 2
Saxena, A., Bai, B., Hou, S., Jiang, L., Ying, T., Miersch, S., Sidhu, S. S., & Wu, D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8648-4_21 · Cited by 3
Biology of Gut Immunoglobulins
Johansen, F., Yen, E. H., Dickinson, B. L., Yoshida, M., Claypool, S. M., Blumberg, R. S., & Lencer, W. I. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50046-5 · Cited by 3
Song, Y., Deng, X., Shi, W., Tang, F., Huang, W., Gong, L., & Qin, Q. (2021) · Journal of Immunological Methods · doi:10.1016/j.jim.2021.113180 · Cited by 2
Yoo, E. M., & Morrison, S. L. (2009) · Wiley eBooks · doi:10.1002/9780470054581.eib044 · Cited by 3
Self-citationTemporal dynamics of IgG-mediated immunometabolic dysfunction: from acute obesity to chronic aging
Kim, S., Kim, J.-H., Lee, H.-L., & Kim, M. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661391 · Cited by 1
Xu, F., Ye, H., Liu, X., Chen, F., Ding, X., Chen, X., & Li, L. (2015) · Gene · doi:10.1016/j.gene.2015.01.011 · Cited by 1
Regulation of Immunological Responses by the Neonatal Fc Receptor for IgG, FcRn
Baker, K., Räth, T., & Blumberg, R. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7107-3_8 · Cited by 2
Novel Constructs—Half-Life Extensions
Sun, J., & Michaels, M. L. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-90603-4_23 · Cited by 1
Polarised Transfer of Proteins Through the Syncytiotrophobalst and Tissue Culture Cell Lines
Berencsi, G., & Ördög, K. (2012) · Springer eBooks · doi:10.1007/978-94-007-4216-1_7 · Cited by 1
Haarberg, K. M. K. (2011) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-3048 · Cited by 2
Joseph, S. B., Prabhu, S., & Boswell, C. A. (2015) · Wiley eBooks · doi:10.1002/9780470571224.pse542 · Cited by 1
Overview Of Antibody- Based Therapeutics Present And Future Promise
Grewal, I. S. (2009) · CRC Press eBooks · doi:10.1201/9781420063219-6 · Cited by 1
Protein Engineering: Methods and Applications
Dobson, C., & Dall’Acqua, W. F. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527699124.ch7 · Cited by 1
Hardiansyah, D., & Ng, C. M. (2019) · Wiley eBooks · doi:10.1002/9781119289234.ch13 · Cited by 1
Overview Of Antibody- Based Therapeutics Present And Future Promise
Grewal, I. S. (2009) · CRC Press eBooks · doi:10.1201/9781420063219.sec1 · Cited by 1
Binding Proteins | Antibodies: Structure and Immune Effector Functions
Locker, K. C. S., & Herr, A. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21356-3 · Cited by 1
The Diverse Roles of FcRn: Implications for Antibody Engineering
Ward, E. S., & Ober, R. J. (2012) · Wiley eBooks · doi:10.1002/9783527644827.ch11 · Cited by 2
Experimental design of a novel target to isolate HCV monoclonal antibodies
Brice, S. (2014) · Nottingham ePrints (University of Nottingham)
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
Stork, C. R. (2009) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1885
Modulation of Serum Protein Homeostasis and Transcytosis by the Neonatal Fc Receptor
Dall’Acqua, W. F., & Wu, H. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch14
The Biology of the Neonatal Fc Receptor (FcRn)
Kim, J. (2012) · Wiley eBooks · doi:10.1002/9783527644827.ch8 · Cited by 1
Immune modulation by antibodies and antibody receptors
Tayer-Shifman, O. E., & Ilan, Y. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770802547196
Influence of the antibody variable domain on FcRn-dependent pharmacokinetics
Schoch, A. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17528
Muniz, B. P. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-20032012-161225 · Cited by 3
Immunological aspects of maternal-foetal interactions in mice
Arvola, M. (2001) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Cianga, P. (2010) · Analele Stiintifice ale Universitatii "Alexandru Ioan Cuza" din Iasi Sec. II a. Genetica si Biologie Moleculara
Morrow, K. J. (2016) · Wiley eBooks · doi:10.1002/9781118940648.ch21
Metadata
- Authors
- Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J.
- Affiliations
- California Institute of Technology (US)
- Northwell Health (US)
- University of California, Los Angeles (US)
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-11-01
- Volume
- 34
- Issue
- 45
- Pages
- 14649-14657
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2065219066
- Cited by
- 317
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 8 · 2018: 18 · 2017: 13 · 2016: 8 · 2015: 17 · 2014: 20 · 2013: 13 · 2012: 15
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca016858-25)
- National Cancer Institute (CA-16858)
- National Institute of Allergy and Infectious Diseases (AI29470)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal health and immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- neonatal Fc receptor, IgG, pH-dependent binding, ligand-receptor interactions, binding affinity, maternal IgG transfer
- MeSH terms
- Antibodies, Monoclonal, Binding Sites, Computer Graphics, Histidine, Humans, Hydrogen-Ion Concentration, Immunoglobulin G, Infant, Newborn, Kinetics, Models, Molecular, Protein Binding, Receptors, Fc, Biosensing Techniques, Mutagenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.